Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05772689 · ClinicalTrials.gov registry record · NA
Caregiving While Black
A NA study of Caregiver Burden, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 1
- Study location
NCT05772689: Recruiting NA study of Caregiver Burden, sponsored by Emory University.
NCT05772689 is a NA study of Caregiver Burden that is actively recruiting participants, run by Emory University. The registered enrollment target is 140 participants, below the 241-participant average among 41 other Caregiver Burden trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05772689, a NA study of Caregiver Burden, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to revise and test an online education program designed to enhance the mastery of Black American caregivers to provide care to family members or friends living with a dementia illness. This study has two phases, and participants will take part in Phase 1 and/or Phase 2 of this study. Participants will take part in one and/or both phases in this study if they are a caregiver to a person living with dementia. Caregivers must self-identify as Black American and as the unpaid principal caregiver of a community-dwelling person living with a dementia illness and who is the principal companion of that person during healthcare encounters. Caregivers must also be 18 years of age or older and will be providing at least some hands-on care multiple times a week, if not daily. It is preferred that participants have access to and the ability to use broadband internet services to engage with the Caregiving While Black course. Participants should not have a plan in place to move the person living with a dementia illness to an institutional setting within the next six months.
Primary Outcome
Participants will complete the Caregiver Mastery questionnaire. A 3 3-5 item scale of caregiver mastery of caregiving situations, indicating the extent to which respondents agree (5) or disagree (1) with each item. The instrument includes categories of relational deprivation, caregiving competence, and management of situations. Total scores range from 14 to 56, where higher scores indicate feeling a greater sense of mastery of caregiving.
Conditions Studied
Interventions
- OTHER Usual Care
- OTHER Caring While Black
Study Locations (1)
Georgia
- Emory University - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2023-05-06 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT05772689 shows while recruiting
NCT05772689 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 241-participant average among 41 other Caregiver Burden trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Caregiver Burden appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.
NCT05772689 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05772689 about?
NCT05772689 is a clinical study titled "Caregiving While Black". The goal of this project is to revise and test an online education program designed to enhance the mastery of Black American caregivers to provide care to family members or friends living with a dementia illness. This study has two phases, and participants will take part in Phase 1 and/or Phase 2 o...
What is the current status of trial NCT05772689?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2023-05-06. Estimated completion is 2026-10.
What conditions does trial NCT05772689 study?
This clinical trial studies the following conditions: Caregiver Burden.
What interventions are being tested in trial NCT05772689?
The interventions under investigation include: Usual Care (OTHER), Caring While Black (OTHER).
Who is sponsoring clinical trial NCT05772689?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05772689 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregiver Burden
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05772689's enrollment target sits among peer trials
140 18th of 41 higher than 23 of 41 other Caregiver Burden trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregiver Burden trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Caregiver Stress and Sleep Study
RECRUITING · NA
-
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Telephone Support in Advanced Gastrointestinal Cancer
RECRUITING · NA
-
Support Via Technology: Living and Learning With Advancing Dementia-REVISED
RECRUITING · NA
-
DECIDE: Dyads and Families
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI